Water vapor or surgery? new study aims to protect ejaculation in prostate treatment
NCT ID NCT07648888
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two minimally invasive procedures for men with an enlarged prostate: water vapor thermal therapy (Rezum) and ejaculation-sparing surgery. It includes 120 sexually active men aged 50 or older who have moderate-to-severe urinary symptoms. The goal is to see which treatment better preserves ejaculation while improving urine flow over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Water vapor thermal therapy (Rezum) and ejaculation-sparing bipolar transurethral enucleation of the prostate (ES-B-TUEP)
What this could lead to
If successful, this could help doctors choose which procedure better preserves ejaculation while relieving urinary symptoms in men with an enlarged prostate.
What could go wrong
This is a small, non-randomized study, so results may not apply to all men. Both procedures carry risks like infection, bleeding, or urinary problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOWER URINARY TRACT SYMPTOMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Urology- Beni-Suef University Hospitals
RECRUITINGBanī Suwayf, Beni Suweif Governorate, 02456, Egypt
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact